Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study
Chen‐Yi Wu, Chen-Yi Wu, Chun‐Ying Wu, Chun‐Ying Wu, Chung‐Pin Li, Yiing‐Jenq Chou, Yi-Hsian Lin, Yun-Ting Chang
Topics & Concepts
MedicineInternal medicineDipeptidyl peptidase-4 inhibitorDipeptidyl peptidase-4Bullous pemphigoidDiabetes mellitusPropensity score matchingCohortSitagliptinMetforminGastroenterologyPopulationRetrospective cohort studyInsulinType 2 diabetesEndocrinologyImmunologyEnvironmental healthAntibodyAutoimmune Bullous Skin DiseasesDiabetes Treatment and ManagementCoagulation, Bradykinin, Polyphosphates, and Angioedema